About this trial
Lung cancer can be detected via screening of high-risk individuals, i.e current or ex-heavy smokers, with low-dose computer tomography (LDCT) of thorax. The National Lung Screening Trial in US and the NELSON trial in Europe demonstrated reduction in lung cancer mortality with LDCT screening for lung cancer. In Hong Kong, however, there is a prominence of female never-smokers with lung cancer. There is no identifiable risk factors for non-smokers with lung cancer except family history of lung cancer. The hypothesis is that lung cancer screening for subjects with family history of lung cancer, can detect early lung cancer.
Eligibility criteria
Qualifiers
Age 50-75, men or women, smokers or non-smokers
Being first degree relatives (Siblings, children, and parents) of lung cancer subjects
Having no known lung cancer before
Disqualifiers
Non-Chinese
Mentally incompetent to give informed consent
Trial design
Treatments tested in this trial
- Low dose CT thorax
- Low dose CT thorax
Treatment groups
Sponsors and collaborators
The University of Hong Kong
Lead sponsor
The Queen Elizabeth Hospital
Collaborator
Kwong Wah Hospital
Collaborator
Hong Kong Sanatorium & Hospital
Collaborator